Related Experiment Video
Updated: Sep 16, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cyclin-Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications.
Janhabee Shrestha1, Jason Blanchard1, Solomon Tadesse1
1Biomedical and Pharmaceutical Sciences, L. S. Skaggs College of Pharmacy, Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID, 83209, USA.
Cyclin-dependent kinase 11 (CDK11) is crucial for gene transcription and cell division. Inhibiting CDK11 may offer a new strategy against cancer and other diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- Cyclin-dependent kinase 11 (CDK11) is a key kinase regulating transcription and RNA splicing.
- CDK11's functions include promoting transcriptional elongation, 3'-end processing, and chromosome segregation.
- It is vital for global pre-mRNA splicing by activating the spliceosome.
Purpose of the Study:
- To provide a comprehensive overview of CDK11's biological functions and regulation.
- To discuss CDK11's involvement in cancer, viral, and neurodegenerative diseases.
- To highlight the development of CDK11 inhibitors as potential therapeutics.
Main Methods:
- Literature review of CDK11's role in cellular processes.
- Analysis of CDK11's involvement in disease pathogenesis.
- Summary of current research on CDK11 inhibitor development.
Main Results:
- CDK11 inhibition disrupts transcription and cell cycle progression.
- CDK11 is implicated in cancer proliferation, HIV-1 replication, and Alzheimer's disease pathology.
- OTS964 is an example of a CDK11 inhibitor advancing understanding and therapeutic prospects.
Conclusions:
- CDK11 is a critical regulator of fundamental cellular processes.
- Dysregulation of CDK11 is linked to significant human diseases.
- Targeting CDK11 presents a promising therapeutic strategy, particularly for cancers.
More Related Videos
11:11Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: